Annual Dividend Yield

Your own ranges are part of Powerpack. Powerpack

Annual Dividend Rate

Your own ranges are part of Powerpack. Powerpack

Payout Ratio

Your own ranges are part of Powerpack. Powerpack

Dividend Safety Score

Your own ranges are part of Powerpack. Powerpack

Dividend Champion (3y)
Dividend Champion (5y)
Dividend Champion (10y)
Dividend Aristocrat
Dividends Paid (Common)

Your own ranges are part of Powerpack. Powerpack

Issuance/Purchase of Shares

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow Yield

Your own ranges are part of Powerpack. Powerpack

Showing the 10 largest of 47 matches.
2 filters active
median
thirds
  1. ICICI Bank Limited

    IBN Financial · Banks Regional · IN

    $33.80 +13.2% 1Y
    Low $25.08 High $34.08

    ICICI Bank Limited (IBN) is one of India’s leading private sector banks, headquartered in Mumbai, Maharashtra. Established in 1994, ICICI Bank was initially promoted by ICICI Limited, an Indian financial institution, as a wholly-owned subsidiary.

    Market cap $116.8B
    Revenue growth (Q) +5.71%
    EPS growth (Q) +26.4%
    FCF growth (Q) −61.2%
    Revenue growth (next yr) —
    Net margin 17.9%
    ROE 15.2%
    P/E 19.7×
    Forward P/E —
    P/FCF 5.1×
    Dividend yield 0.74%
    Insider ownership 0.00%
    Insider buys / sells (12M) — $3.0M
    Reported FY2023 FY2024 FY2025 FY2026 TTM
    Revenue $23.3B $28.6B $34.8B $35.3B $35.5B
    EPS $1.12 $1.39 $1.56 $1.57 $1.68
    Free cash flow −$743.9M $18.6B $13.9B $7.2B $24.0B
    Net debt $6.6B $5.4B $573.5M −$5.1B $2.1B

    This screen

    Market Cap Now $116.8B
  2. Moderna, Inc.

    MRNA Healthcare · Biotechnology · US

    $253.57 +942.2% 1Y
    Low $22.28 High $267.50

    Moderna is a biotechnology company based in Cambridge, led by chief executive Stéphane Bancel. It develops medicines using messenger RNA, or mRNA: instructions that direct the body’s cells to make proteins.

    Market cap $96.4B
    Revenue growth (Q) +29.2%
    EPS growth (Q) +178.4%
    FCF growth (Q) −90.9%
    Revenue growth (next yr) +8.13%
    Net margin −110.5%
    ROE −34.5%
    P/E —
    Forward P/E −26.1×
    P/FCF —
    Dividend yield —
    Insider ownership 8.93%
    Insider buys / sells (12M) — $81.6M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $19.3B $6.8B $3.2B $1.9B $2.5B
    EPS $20.12 −$12.33 −$9.28 −$7.26 −$7.08
    Free cash flow $4.6B −$3.8B −$4.1B −$2.1B −$2.0B
    Net debt −$9.0B −$8.0B −$7.0B −$5.2B −$5.2B

    This screen

    Market Cap Now $96.4B
  3. Becton, Dickinson and Company

    BDX Healthcare · Medical Instruments & Supplies · US

    $212.21 +49.5% 1Y
    Low $129.89 High $214.88

    Becton, Dickinson and Company, known as BD, develops, manufactures and sells medical supplies, devices and equipment used in healthcare and drug delivery. Its products range from needles, syringes and blood collection tubes to infusion pumps, pharmacy automation and devices used in surgery.

    Market cap $58.2B
    Revenue growth (Q) −10.5%
    EPS growth (Q) +47.9%
    FCF growth (Q) −31.6%
    Revenue growth (next yr) −11.7%
    Net margin 5.66%
    ROE 0.00%
    P/E 51.1×
    Forward P/E 39.2×
    P/FCF 19.7×
    Dividend yield 1.87%
    Insider ownership 0.41%
    Insider buys / sells (12M) — $2.8M
    Reported FY2023 FY2024 FY2025 FY2026
    Revenue $19.4B $20.2B $21.8B $19.5B
    EPS $4.94 $5.93 $5.82 $4.09
    Free cash flow $2.1B $3.1B $2.7B $2.9B
    Net debt $13.2B $15.6B $16.8B $12.4B

    This screen

    Market Cap Now $58.2B
  4. BeOne Medicines Ltd. - Sponsored ADR

    ONC Healthcare · Biotechnology · CH

    $406.26 +22.2% 1Y
    Low $253.95 High $410.71

    BeOne Medicines discovers, develops and sells medicines for cancer. Founded in 2010, it is a Swiss-incorporated holding company whose operations are conducted mainly through subsidiaries in the United States, China, the United Kingdom and Australia.

    Market cap $40.4B
    Revenue growth (Q) +33.8%
    EPS growth (Q) +144.1%
    FCF growth (Q) +33.6%
    Revenue growth (next yr) +26.6%
    Net margin 13.9%
    ROE 18.4%
    P/E 68.9×
    Forward P/E 48.8×
    P/FCF 31.7×
    Dividend yield —
    Insider ownership 7.04%
    Insider buys / sells (12M) — $391.3M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $1.4B $2.5B $3.8B $5.3B $6.6B
    EPS −$19.43 −$8.45 −$6.12 $2.53 $5.68
    Free cash flow −$1.8B −$1.7B −$638.0M $921.7M $1.4B
    Net debt −$4.0B −$3.0B −$2.5B −$3.6B −$5.0B

    This screen

    Market Cap Now $40.4B
  5. Chunghwa Telecom Co., Ltd.

    CHT Communication Services · Telecom Services · TW

    $49.93 +19.2% 1Y
    Low $39.28 High $50.15

    Chunghwa Telecom Co., Ltd. (CHT) is Taiwan’s largest telecommunications company, established on June 15, 1996, as part of the Taiwanese government’s efforts to privatize and modernize the telecommunications industry. Headquartered in Taipei, Taiwan, Chunghwa Telecom has played a pivotal role in the development of Taiwan’s telecommunications infrastructure.

    Market cap $37.9B
    Revenue growth (Q) +5.50%
    EPS growth (Q) +2.33%
    FCF growth (Q) +39.6%
    Revenue growth (next yr) —
    Net margin 16.1%
    ROE 10.3%
    P/E 30.3×
    Forward P/E —
    P/FCF 22.8×
    Dividend yield 3.31%
    Insider ownership 0.00%
    Insider buys / sells (12M) — —
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $7.1B $7.3B $7.0B $7.5B $7.8B
    EPS $1.58 $1.53 $1.49 $1.60 $1.65
    Free cash flow $1.4B $1.4B $1.5B $1.6B $1.7B
    Net debt −$684.0M −$703.0M −$834.0M −$1.1B −$1.7B

    This screen

    Market Cap Now $37.9B